Board of directors
Ian spent most of his career with Nortel Technologies (formerly STL Laboratories) rising by 1991 to Group Managing Director of BNR Europe with responsibility for Nortel's 1500-person research and development group.
In 1994 Ian took responsibility for all Nortel's public network products in Europe, before becoming Vice President and Chief Engineer of Nortel Plc in 1998, with responsibility for all Nortel products in the European market.
Ian is also director of MLL Telecom, Chairman of Cyberexports Ltd and Chairman of North London Leadership Ltd. He was honoured by Her Majesty the Queen with an MBE in 1988 for his innovations in the design and manufacture of radio equipment for communications and navigation.
Company Secretary, CFO Solutions Ltd
Nigel is co-founder of CFO Solutions Ltd, a company specialising in providing financial leadership to early stage companies. CFO Solutions Ltd is contracted to provide CFO services to Mesophotonics and was founded in 2001 with Nigel Souster formally a partner at PWC with over 20 years financial management experience.
James joined Mesophotonics in March 2003 with a mission to accelerate the transition to a commercial business. In 1995 James joined Bookham Technology, initially with business unit responsibility for Sensor Products. He subsequently became Bookham’s Director of Product Engineering for their full products range.
In 1999 James became Director of Marketing, playing a key role in preparing Bookham for IPO in 2000. In 2001 James joined Teem Photonics as VP of Business Development & Marketing developing the companies growth strategies, exiting the company following a successful round of fundraising in 2003.
Jamie has worked as a private equity investor for the past eight years. Previously at 3i, he joined Quester in 2000 and is now a director in the ICT team, specialising in wireless and fixed line communications. He is also responsible for managing the Sulis University Challenge Fund which invests in spin-outs from Bath, Bristol and Southampton Universities, pulling together management teams and building robust businesses based on the commercialisation of leading-edge technology.
Whilst in Deloitte & Touche’s strategic consulting division, advising on a US-based private equity transaction gave Jamie a taste for venture capital. He joined 3i in 1997 and worked in the London buyout team on a number of successful leveraged transactions including MORI, a public opinion research agency, Coutts Consulting, a UK-based outplacement and career development consultancy, and Safetynet, a computer disaster recovery firm.
He now represents Quester on the boards of Azea, Antenova, Ilika, Argelcom and Mesophotonics and has recently stepped off the board of OD2 after achieving a profitable exit to Loudeye, a Nasdaq listed company. He qualified as a chartered accountant with Deloitte & Touche and has a mathematics degree from Oxford University.
Following his thesis in theoretical physics at the CEA labs, Francois has been a research engineer in the field of electronic materials in the central laboratory of Thales (former Thomson CSF) and in the laboratory of Ecole des Mines de Paris, from 1988 to 1991. He then joined Thomson Broadcast, a subsidiary of Thomson Multimedia, where he was product marketing manager and product line manager, from 1992 to 1995.
Francois was then with McKinsey as a consultant in the fields of Hi Tech and Telecom from 1995 to 2002. He joined Auriga Partners in June 2002.
François is an alumni from Ecole Normale Supérieure, and belongs to the Corps des Mines. He is also doctor and agrégé in physics and is specialised in the fields of electronics, telecoms and information technology.
Peter is a representative director of BTG plc where he is an Investment Manager. Prior to the appointment of James McKenzie he was Interim CEO at Mesophotonics, having taken the initiative in creating the company together with the founders.
Previously, Peter has worked at Cambridge Consultants Ltd, spent seven years at a venture capital funded spin-off company from CCL, and two years at Dell Computer Corporation. He has a BSc in Electronic Engineering and an MBA.
W Alan Hulme
Specialising in medical microbiology/pathology in his early career, Alan managed the technical side of a public health laboratory for some time before moving towards an international commercial career spanning 25 years. This lead to a series of senior commercial positions to CEO and board level in technology companies located in the Far East, USA and across Europe.
Primary markets covered include life sciences, biopharmaceutical/ biotechnology, clinical diagnostics, industrial diagnostics, analytical instrumentation, laboratory/industrial filtration and air handling/purification. Alan has been involved with companies including Flow Laboratories Inc (NYSE), Idexx Laboratories Inc (NASDAQ) and Affymetrix Inc (NASDAQ).